Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
CSL ASX:CSL |
66,78 B | 9,75% | 4/6 | -2,26% | 62,20% | 42,80% | DOWN |
|
Telix Pharmaceuticals ASX:TLX |
4,96 B | 140,36% | 3/6 | 13,01% | 85,73% | 45,83% | DOWN |
|
Mesoblast ASX:MSB |
2,74 B | -23,16% | 4/6 | 580,42% | 55,49% | 81,13% | DOWN |
|
Neuren Pharmaceuticals ASX:NEU |
1,59 B | 164,36% | 4/6 | 12,09% | -3,50% | 85,14% | DOWN |
|
PYC Therapeutics ASX:PYC |
1,16 B | 0,00% | 1/3 | -33,14% | -398,84% | 228,81% | DOWN |
|
Opthea ASX:OPT |
0,74 B | -43,15% | 1/5 | -100,00% | 0,00% | 150,00% | DOWN |
|
Racura Oncology Ltd ASX:RAC |
0,50 B | 28,72% | 0/0 | -33,81% | -137,15% | 171,27% | UP |
|
Clinuvel Pharmaceuticals ASX:CUV |
0,46 B | 20,60% | 5/6 | 2,56% | 69,05% | 142,02% | DOWN |
|
Cogstate ASX:CGS |
0,39 B | 0,00% | 5/5 | 7,82% | -2,41% | 38,26% | UP |
|
Tetratherix ASX:TTX |
0,25 B | 9,94% | 0/0 | 43,80% | -113,59% | 11,74% | DOWN |
|
Orthocell ASX:OCC |
0,22 B | 0,00% | 0/0 | 100,00% | -698,13% | 51,22% | DOWN |
|
Starpharma Holdings ASX:SPL |
0,22 B | 0,00% | 4/6 | 100,00% | 36,91% | 53,85% | UP |
|
Actinogen Medical ASX:ACW |
0,14 B | -11,78% | 0/2 | -100,00% | -1368,53% | 100,00% | DOWN |
|
Paradigm Biopharmaceuticals ASX:PAR |
0,10 B | -100,00% | 0/0 | 0,00% | 0,00% | 539,13% | DOWN |
|
Alterity Therapeutics ASX:ATH |
0,10 B | -15,84% | 1/4 | -100,00% | -613,34% | 300,00% | UP |
|
Botanix Pharmaceuticals ASX:BOT |
0,08 B | 0,00% | 1/5 | 580,95% | 98,57% | 625,00% | DOWN |
|
Amplia Therapeutics ASX:ATX |
0,08 B | 0,00% | 0/0 | 100,00% | 0,00% | 162,50% | UP |
|
Cynata Therapeutics ASX:CYP |
0,07 B | -33,47% | 1/6 | 25,64% | -200,57% | 266,67% | UP |
|
Immutep ASX:IMM |
0,06 B | -26,95% | 1/6 | 184,19% | 88,47% | 75,00% | DOWN |
|
Prescient Therapeutics ASX:PTX |
0,06 B | 0,00% | 2/4 | 0,00% | -624,08% | 133,33% | UP |
